<DOC>
	<DOCNO>NCT01380353</DOCNO>
	<brief_summary>The purpose study look way improve breast cancer treatment give breast cancer drug skin breast . The drug use study diclofenac epolamine patch nonsteroid anti-inflammatory pain reliever . The drug amount gather breast , application patch skin breast , measure compare amount find breast patch apply skin belly .</brief_summary>
	<brief_title>Test Uniformity Transdermal Drug Delivery Breast Using Diclofenac Epolamine</brief_title>
	<detailed_description>This randomize study participant group 1 apply diclofenac epolamine patch breast participant group 2 apply drug abdomen . Participants instruct apply new patch every 12 hour 3 day . Total participation study three day , end day surgery . On day surgery , participant blood drawn measure level diclofenac epolamine body , final patch remove .</detailed_description>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Diclofenac hydroxyethylpyrrolidine</mesh_term>
	<criteria>Women age 18 80 year , undergo total mastectomy , without axillary surgery diagnosis prevention breast cancer . ECOG performance status less 2 . Ability understand willingness sign write informed consent . Participants must normal organ marrow function Prior history ipsilateral breast radiotherapy . Pregnant woman actively breastfeed preoperative period exclude . Inability discontinue aspirin warfarin use period participation . Known allergy diclofenac epolamine , aspirin , diclofenac ( Cataflam , Voltaren ) , another nonsteroidal antiinflammatory drug ( NSAID ) . Renal failure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Women undergo total mastectomy</keyword>
	<keyword>Breast cancer prevention</keyword>
</DOC>